Advanced Nanotechnology for Enhancing Immune Checkpoint Blockade Therapy.

Hong Yeol Yoon, Subramanian Tamil Selvan, Yoosoo Yang, Min Ju Kim, Dong Kee Yi, Ick Chan Kwon, Kwangmeyung Kim, Engineering nanoparticle strategies for effective cancer immunotherapy. Biomaterials. ,vol. 178, pp. 597- 607 ,(2018) , 10.1016/J.BIOMATERIALS.2018.03.036

Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber, Fay Wong, Nilofer S Azad, Agnieszka A Rucki, Dan Laheru, Ross Donehower, Atif Zaheer, George A Fisher, Todd S Crocenzi, James J Lee, Tim F Greten, Austin G Duffy, Kristen K Ciombor, Aleksandra D Eyring, Bao H Lam, Andrew Joe, S Peter Kang, Matthias Holdhoff, Ludmila Danilova, Leslie Cope, Christian Meyer, Shibin Zhou, Richard M Goldberg, Deborah K Armstrong, Katherine M Bever, Amanda N Fader, Janis Taube, Franck Housseau, David Spetzler, Nianqing Xiao, Drew M Pardoll, Nickolas Papadopoulos, Kenneth W Kinzler, James R Eshleman, Bert Vogelstein, Robert A Anders, Luis A Diaz Jr, None, Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade Science. ,vol. 357, pp. 409- 413 ,(2017) , 10.1126/SCIENCE.AAN6733

Isabel Gonçalves Silva, Inna M. Yasinska, Svetlana S. Sakhnevych, Walter Fiedler, Jasmin Wellbrock, Marco Bardelli, Luca Varani, Rohanah Hussain, Giuliano Siligardi, Giacomo Ceccone, Steffen M. Berger, Yuri A. Ushkaryov, Bernhard F. Gibbs, Elizaveta Fasler-Kan, Vadim V. Sumbayev, The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells. EBioMedicine. ,vol. 22, pp. 44- 57 ,(2017) , 10.1016/J.EBIOM.2017.07.018

Yang Liu, Paolo Maccarini, Gregory M. Palmer, Wiguins Etienne, Yulin Zhao, Chen-Ting Lee, Xiumei Ma, Brant A. Inman, Tuan Vo-Dinh, Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers Scientific Reports. ,vol. 7, pp. 8606- ,(2017) , 10.1038/S41598-017-09116-1

Thomas Powles, Peter H. O'Donnell, Christophe Massard, Hendrik-Tobias Arkenau, Terence W. Friedlander, Christopher J. Hoimes, Jae Lyun Lee, Michael Ong, Srikala S. Sridhar, Nicholas J. Vogelzang, Mayer N. Fishman, Jingsong Zhang, Sandy Srinivas, Jigar Parikh, Joyce Antal, Xiaoping Jin, Ashok K. Gupta, Yong Ben, Noah M. Hahn, Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study JAMA Oncology. ,vol. 3, ,(2017) , 10.1001/JAMAONCOL.2017.2411

Amin Reza Nikpoor, Jalil Tavakkol-Afshari, Kayvan Sadri, Seyed Amir Jalali, Mahmoud Reza Jaafari, Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies Nanomedicine: Nanotechnology, Biology and Medicine. ,vol. 13, pp. 2671- 2682 ,(2017) , 10.1016/J.NANO.2017.08.010

Rinat Meir, Katerina Shamalov, Tamar Sadan, Menachem Motiei, Gur Yaari, Cyrille J. Cohen, Rachela Popovtzer, Fast Image-Guided Stratification Using Anti-Programmed Death Ligand 1 Gold Nanoparticles for Cancer Immunotherapy ACS Nano. ,vol. 11, pp. 11127- 11134 ,(2017) , 10.1021/ACSNANO.7B05299

A. Rotte, J.Y. Jin, V. Lemaire, Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy Annals of Oncology. ,vol. 29, pp. 71- 83 ,(2018) , 10.1093/ANNONC/MDX686

Daniela Schmid, Chun Gwon Park, Christina A. Hartl, Nikita Subedi, Adam N. Cartwright, Regina Bou Puerto, Yiran Zheng, James Maiarana, Gordon J. Freeman, Kai W. Wucherpfennig, Darrell J. Irvine, Michael S. Goldberg, T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity Nature Communications. ,vol. 8, pp. 1747- 1747 ,(2017) , 10.1038/S41467-017-01830-8

Manish R Patel, John Ellerton, Jeffrey R Infante, Manish Agrawal, Michael Gordon, Raid Aljumaily, Carolyn D Britten, Luc Dirix, Keun-Wook Lee, Mathew Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Arnold B Gelb, Junyuan Xiong, Galit Rosen, James L Gulley, Andrea B Apolo, Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial Lancet Oncology. ,vol. 19, pp. 51- 64 ,(2018) , 10.1016/S1470-2045(17)30900-2